GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Institutional Ownership

TCM Biotech International (ROCO:4169) Institutional Ownership : 0.02% (As of Jun. 19, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TCM Biotech International's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TCM Biotech International's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TCM Biotech International's Float Percentage Of Total Shares Outstanding is 0.00%.


TCM Biotech International Institutional Ownership Historical Data

The historical data trend for TCM Biotech International's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Institutional Ownership Chart

TCM Biotech International Historical Data

The historical data trend for TCM Biotech International can be seen below:

2023-09-30 2023-10-31 2023-11-30
Institutional Ownership 0.02 0.02 0.02

TCM Biotech International Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


TCM Biotech International (ROCO:4169) Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines